Pricing Log in Create free account

Enveric Biosciences, Inc. (ENVB) vs Evogene Ltd. (EVGN)

Enveric Biosciences, Inc. and Evogene Ltd. are both Biotechnology companies. Enveric Biosciences, Inc. and Evogene Ltd. are of similar size ($6.3M and $6.2M). Enveric Biosciences, Inc. grew revenue faster over the last twelve months: −13.9% against −54.7%. Enveric Biosciences, Inc. has the higher net margin (0.00% vs −547.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Enveric Biosciences, Inc. leads on 12 and Evogene Ltd. on 4.

Valuation

Metric ENVB EVGN Biotechnology median
P/E n/m n/m 8.50
P/S 0.16 2.87 9.71
P/B 0.68 0.82 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.29 0.43 0.64
EV/Sales (0.07) (2.77) 9.21
Earnings yield (481.51%) (233.33%) (33.15%)
Free cash flow yield (193.82%) (226.59%) (25.50%)

Profitability

Metric ENVB EVGN Biotechnology median
Gross margin 0.00% (67.59%) 65.16%
Operating margin 0.00% (851.42%) 0.00%
Net margin 0.00% (547.62%) 0.00%
Free cash flow margin 0.00% (650.63%) 0.00%
Return on equity (235.48%) (100.03%) (56.36%)
Return on assets (193.53%) (38.31%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ENVB EVGN Biotechnology median
Revenue growth (TTM) (13.93%) (54.71%) 6.02%
EPS growth (last fiscal year) 84.14% 62.63% 30.26%
Revenue growth, 5-year CAGR — 29.94% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENVB EVGN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.21 3.57 4.72
Net debt to EBITDA 0.55 1.12 0.96

Dividend

Metric ENVB EVGN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ENVB EVGN Biotechnology median
Market cap 6.22m 6.32m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack